News & Therapies
Corporate Member Update: Bristol Myers Squibb
Omaha World Herald Letter to the Editor: New Policy a Disservice to Cancer Patients
Conquer Cancer – Nebraska Oncology Society Young Investigator Award
Corporate Member Update- Merck
Corporate Member Update- Jazz Pharmaceuticals
Corporate Member Update- Johnson & Johnson
Corporate Member Update- KEYTRUDA
Corporate Member Update- HCPCS Code for Keytruda
Corporate Member Update- KEYTRUDA® (pembrolizumab)
Corporate Member Update: Amgen
IMDELLTRA® (tarlatamab-dlle) November, 2025 IMPORTANT UPDATE: Full FDA Approval Granted in 2L ES‑SCLC IMDELLTRA® (tarlatamab‑dlle) is now fully FDA‑approved for the treatment of adult patients with extensive stage small cell lung cancer (ES‑SCLC) with disease...